Vanda Pharmaceuticals
VNDA
#8239
Rank
โ‚น30.07 B
Marketcap
โ‚น500.14
Share price
-3.36%
Change (1 day)
22.04%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -โ‚น14.4 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are โ‚น0.21 Billion. In 2025 the company made an earning of -โ‚น14.6 Billion a decrease over its 2024 earnings that were of -โ‚น3.93 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น14.4 Billion-1.36%
2025 -โ‚น14.6 Billion271.79%
2024 -โ‚น3.93 Billion191.43%
2023 -โ‚น1.35 Billion-320.45%
2022 โ‚น0.61 B-84.99%
2021 โ‚น4.07 B54.8%
2020 โ‚น2.62 B19.42%
2019 โ‚น2.20 B4.93%
2018 โ‚น2.09 B-228.6%
2017 -โ‚น1.64 Billion-8.98%
2016 -โ‚น1.8 Billion-53.79%
2015 -โ‚น3.88 Billion-30.18%
2014 -โ‚น5.56 Billion173.08%
2013 -โ‚น2.04 Billion-25.33%
2012 -โ‚น2.73 Billion163.61%
2011 -โ‚น1.04 Billion-221.15%
2010 โ‚น0.85 B-124.53%
2009 -โ‚น3.48 Billion-29.44%
2008 -โ‚น4.94 Billion-36.2%
2007 -โ‚น7.73 Billion21.81%
2006 -โ‚น6.35 Billion170.55%
2005 -โ‚น2.35 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น2.508 T-16,300.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.523 T-9,942.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น1.022 T-6,704.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.005 T-19,508.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น1.269 T-8,301.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น926.60 B-6,084.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-โ‚น0.28 Billion-98.25%๐Ÿ‡บ๐Ÿ‡ธ USA